A low rivaroxaban plasma level may indicate anticoagulation undertreatment

2Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Few reports have been published on the correlation between plasma concentrations of rivaroxaban and clinical outcome in patients who have experienced venous thromboembolism. This article describes the case of a 44-year-old woman who experienced deep vein thrombosis during anticoagulation therapy with rivaroxaban, with evidence of repeated low plasma levels of the drug. We postulate that the determination of plasma rivaroxaban anti-Xa activity can be useful in the evaluation of anticoagulation therapy in selected cases.

Cite

CITATION STYLE

APA

Romano, S. L., Chiarugi, P., Casini, M., Pellegrini, G., & Ruocco, L. (2018). A low rivaroxaban plasma level may indicate anticoagulation undertreatment. European Journal of Case Reports in Internal Medicine, 5(11). https://doi.org/10.12890/2018_000937

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free